HIT vs PATH
Health In Tech, Inc. Class A Common Stock (HIT) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Health In Tech, Inc. Class A Common Stock (HIT) is a software - application company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported HIT revenue for 2024-12-31 was $19.5M. Net income was $670.5K. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. HIT currently screens at market cap $63.2M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
HIT currently screens at market cap $63.2M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the HIT and PATH stock pages for the full models.
Not investment advice.